Table of contents:
Toragesic is a medicine that contains ketorolac trometamol in its composition, a substance with potent anti-inflammatory and analgesic action, which acts by decreasing the production of substances in the body responsible for causing inflammation and pain, being indicated to relieve acute, moderate or severe pain caused by fractures, renal colic or after surgery, for example.
This medicine can be found in pharmacies or drugstores in the form of a sublingual tablet or drops and must be used with medical indication and guidance.
Toragesic can also be found in the form of an injection, applied directly into a vein or muscle, by a nurse or other he alth professional with knowledge in injectable administration, being used only in hospitals, under the supervision of a he althcare professional.
What is it for
Toragesic is a non-steroidal anti-inflammatory drug indicated for the short-term treatment of moderate to severe acute pain in the following situations:
- Postoperative after gallbladder removal, gynecological or orthopedic surgeries, for example;
- Renal colic;
- Biliary colic;
- Lumbar pain;
- Severe toothache or after dental surgery;
- Soft tissue injuries.
In addition to these situations, the doctor may recommend the use of this medication in other cases of severe pain. See other remedies that can be used to relieve pain.
How to take it
How to use Toragesic varies according to the presentation:
1. Sublingual tablet 10 mg
Toragesic sublingual tablet should be placed under the tongue, without chewing, waiting for it to dissolve completely. The sublingual tablet should not be taken with water.
The recommended dose of Toragesic should be guided by your doctor and includes:
- Adults up to 65 years: the recommended dose is 10 to 20 mg, which corresponds to 1 to 2 sublingual tablets of 10 mg, in a single dose, or 1 sublingual tablet 10 mg every 6 to 8 hours. The maximum dose of Toragesic should not exceed 60 mg per day;
- Adults over 65 years old, weighing less than 50 kg, or suffering from renal failure: the recommended dose is 10 to 20 mg, which corresponds to 1 to 2 10 mg sublingual tablets as a single dose or 1 10 mg sublingual tablet every 6 to 8 hours. The maximum dose of Toragesic should not exceed 40 mg per day.
Treatment duration should not last longer than 5 days.
2. Toragesic drops 20 mg/mL
Toragesic drops contain 20 mg of ketorolac trometamol in each mL of solution and should be taken orally at the times established by your doctor.
The recommended dose of Toragesic drops is 10 to 20 drops in a single dose or 10 drops every 6 to 8 hours and the maximum daily dose should not exceed 60 drops.
For people over 65 years old, who weigh less than 50 kg or suffer from kidney failure, the maximum dose should not exceed 40 drops.
3. Toragesic Injectable 30 mg/mL
Toragesic injectable should be applied directly into the vein, intravenously, or into the muscle, intramuscularly, by a nurse or other he althcare professional with knowledge in injectable administration, and always under medical supervision.
Typical recommended doses of injectable Toragesic are:
Adults under 65 years old
|10 to 60 mg intramuscularly, or 10 to 30 mg intravenously||10 to 30 mg intramuscularly every 4 to 6 hours, or 10 to 30 mg bolus by vein. The maximum daily dose should not exceed 90 mg|
Adults over 65 years old or with kidney failure
|10 to 30 mg intramuscularly, or 10 to 15 mg intravenously||10 to 15 mg intramuscularly every 4 to 6 hours or 10 to 15 mg intravenously every 6 hours. The maximum daily dose should not exceed 60 mg for the elderly and 45 mg for people with renal impairment|
Children over 2 years old
|1.0 mg per kg of body weight intramuscularly, or 0.5 to 1.0 mg per kg of body weight in the vein||1.0 mg per kg of body weight intramuscularly, or 0.5 to 1.0 mg per kg of body weight in the vein|
Treatment time with Toragesic injection should not exceed 2 days to avoid the possibility of side effects.
Possible side effects
The most common side effects that may occur during treatment with Toragesic are headache, dizziness, drowsiness, nausea, poor digestion, abdominal pain or discomfort, stomach pain, diarrhea, increased sweating or bloating if the use of injectables.
Who should not use
Toragesic medicine should not be used by pregnant or breastfeeding women, or by people with stomach or duodenal ulcers, in case of bleeding in the digestive system, hemophilia, blood clotting disorders, after surgery myocardial revascularization, in case of heart or cardiovascular diseases, infarction, stroke, after surgery with high risk of bleeding, bronchial asthma, in case of severe renal failure or nasal polyps.
In addition, it should not be used by smokers, and in case of ulcerative colitis, in addition to not being indicated as a prevention of pain before and during surgeries, due to the inhibition of platelet aggregation and consequent increase in blood pressure. risk of bleeding.